Sort by
Refine Your Search
-
About us UCL Biochemical Engineering (UCL-BE) is a world leader in bioprocessing, where researchers harness cutting-edge facilities and industry partnerships to transform breakthroughs in biology
-
About us UCL Biochemical Engineering (UCL-BE) is a world leader in bioprocessing, where researchers harness cutting-edge facilities and industry partnerships to transform breakthroughs in biology
-
About us UCL Biochemical Engineering (UCL-BE) is a world leader in bioprocessing, where researchers harness cutting-edge facilities and industry partnerships to transform breakthroughs in biology
-
About us This position is a key part of the Manufacturing Research Hub for a Sustainable Future (VaxHub Sustainable), led by UCL Biochemical Engineering and the University of Oxford with a number of
-
£39,148 - £41,833 per annum) with payment at Grade 7 being backdated to the date of final submission of the PhD Thesis. This appointment is subject to UCL Terms and Conditions of Service for Research and
-
siteAvailable for SecondmentNoClosing Date12-Nov-2025 The UCL Division of Surgery and Interventional Science is a collaborative and cross-disciplinary environment where clinicians, engineers, allied health
-
of the post will involve synthesis and manufacture of prototype viral vectors, as well as testing their ability to treat experimental disease models, in vivo and in vitro. Other The advert will close on 05
-
College of Chemistry and Molecular Engineering, Peking University | London, England | United Kingdom | about 8 hours ago
led by the Secrier and Murrell labs at UCL, in collaboration with the Olhede lab at EPFL. The labs are internationally recognised and have a strong track record of postdoc mentoring and career
-
. This project aims to investigate co-cultures and assess their feasibility for cultivated meat production. The challenges to be addressed i nclude improving quality (texture, taste), while reducing manufacturing
-
About us The team in the Department of Biochemical Engineering at UCL carries out world-leading UKRI and company sponsored research on biopharmaceutical formulation. Many antibody-based therapies